Cargando…
Cortisol replacement for severe sepsis and septic shock: what should I do?
Based on several recently completed randomized controlled trials, cortisol replacement is likely to become a standard of care for vasopressor dependent septic shock. Further studies are needed in order to accomplish whether this treatment should be limited to patients with a blunted cortisol respons...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137442/ https://www.ncbi.nlm.nih.gov/pubmed/12133175 http://dx.doi.org/10.1186/cc1486 |
_version_ | 1782120444921380864 |
---|---|
author | Annane, Djillali |
author_facet | Annane, Djillali |
author_sort | Annane, Djillali |
collection | PubMed |
description | Based on several recently completed randomized controlled trials, cortisol replacement is likely to become a standard of care for vasopressor dependent septic shock. Further studies are needed in order to accomplish whether this treatment should be limited to patients with a blunted cortisol response to corticotrophin. Similarly, in patients with severe sepsis who do not need vasopressors, the benefit/risk ratio of cortisol replacement remains to be assessed. |
format | Text |
id | pubmed-137442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1374422003-02-27 Cortisol replacement for severe sepsis and septic shock: what should I do? Annane, Djillali Crit Care Commentary Based on several recently completed randomized controlled trials, cortisol replacement is likely to become a standard of care for vasopressor dependent septic shock. Further studies are needed in order to accomplish whether this treatment should be limited to patients with a blunted cortisol response to corticotrophin. Similarly, in patients with severe sepsis who do not need vasopressors, the benefit/risk ratio of cortisol replacement remains to be assessed. BioMed Central 2002 2002-05-09 /pmc/articles/PMC137442/ /pubmed/12133175 http://dx.doi.org/10.1186/cc1486 Text en Copyright © 2002 BioMed Central Ltd |
spellingShingle | Commentary Annane, Djillali Cortisol replacement for severe sepsis and septic shock: what should I do? |
title | Cortisol replacement for severe sepsis and septic shock: what should I do? |
title_full | Cortisol replacement for severe sepsis and septic shock: what should I do? |
title_fullStr | Cortisol replacement for severe sepsis and septic shock: what should I do? |
title_full_unstemmed | Cortisol replacement for severe sepsis and septic shock: what should I do? |
title_short | Cortisol replacement for severe sepsis and septic shock: what should I do? |
title_sort | cortisol replacement for severe sepsis and septic shock: what should i do? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137442/ https://www.ncbi.nlm.nih.gov/pubmed/12133175 http://dx.doi.org/10.1186/cc1486 |
work_keys_str_mv | AT annanedjillali cortisolreplacementforseveresepsisandsepticshockwhatshouldido |